Unknown

Dataset Information

0

Mousepox in the C57BL/6 strain provides an improved model for evaluating anti-poxvirus therapies.


ABSTRACT: The intranasal lethal mousepox model employing the A/Ncr mouse strain is used to evaluate anti-orthopoxvirus therapies. These infections mimic large droplet transmission and result in 100% mortality within 7-10 days with as little as 1 PFU of ectromelia virus. Unlike the A/Ncr model, humans are less susceptible to lethal respiratory infections with variola virus and monkeypox virus as demonstrated by their lower mortality rates. In this study we show that a low dose intranasal infection of C57BL/6 mice results in 60-80% mortality and better models smallpox. Comparing CMX001 (HDP-cidofovir) efficacy in the A/Ncr strain and the C57BL/6 strain revealed that delayed treatment with CMX001 is more efficacious at preventing severe disease in the C57BL/6 strain. The increased efficacy of CMX001 in C57BL/6 over A/Ncr following an intranasal infection with ectromelia appears to be mediated by a stronger Th1 cell mediated response. Following footpad infection we show that the C57BL/6 strain has earlier and more robust transcriptional activity, Th1 cytokine secretions, antigen presenting activity and IFNgamma splenic CD8+ T cell responses as compared to the A/Ncr strain. As a result of the enhanced immune response in the C57BL/6 strain, non-lethal intradermal ectromelia infections can therapeutically protect up to 3 days following a homologous, lethal intranasal infection - much like how smallpox vaccination can protect humans for up to 4 days following intranasal variola infection.

SUBMITTER: Parker S 

PROVIDER: S-EPMC2801418 | biostudies-literature | 2009 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mousepox in the C57BL/6 strain provides an improved model for evaluating anti-poxvirus therapies.

Parker Scott S   Siddiqui Akbar M AM   Oberle Christina C   Hembrador Ed E   Lanier Randall R   Painter George G   Robertson Alice A   Buller R Mark RM  

Virology 20081218 1


The intranasal lethal mousepox model employing the A/Ncr mouse strain is used to evaluate anti-orthopoxvirus therapies. These infections mimic large droplet transmission and result in 100% mortality within 7-10 days with as little as 1 PFU of ectromelia virus. Unlike the A/Ncr model, humans are less susceptible to lethal respiratory infections with variola virus and monkeypox virus as demonstrated by their lower mortality rates. In this study we show that a low dose intranasal infection of C57BL  ...[more]

Similar Datasets

2020-11-06 | GSE158807 | GEO
| S-EPMC6278034 | biostudies-literature
| S-EPMC10457960 | biostudies-literature
2014-04-28 | E-GEOD-51131 | biostudies-arrayexpress
| S-EPMC4161378 | biostudies-literature
| S-EPMC7406653 | biostudies-literature
| S-EPMC6070928 | biostudies-literature
| S-EPMC3666626 | biostudies-literature
| S-EPMC8232671 | biostudies-literature
| S-EPMC2597719 | biostudies-literature